Looks all fine and great to see some commentary with the 4C.
Cash of $1.58m plus R&D debt facility fully paid not (so $600k available) plus more R&D to be received in Sept quarter plus an acceleration of sales (and cash receipts lag revenues).
The key for me is that the company is doubling the number of chips sent qoq (see GS preso 40k in Dec quarter to over 80k in March quarter to over 170k forecast for June quarter... and likely to be 220-250k in Sept quarter as deliveries to Labcon continue to ramp up towards the 1mpa rate) - cash receipts will likely increase quickly over the next few quarters to reflect that too.
Add to My Watchlist
What is My Watchlist?
